PLAT and hematocrit: However, recombinant tissue plasminogen activator (rtPA), one of the a typical thrombolytic agents, has a short half-life in vivo (approximately < 10 min) and, with late treatment, arises hemorrhagic transformation (HT) can still occur [8–11].